Winston Medical Supply Co., Ltd. (TPEX:6817)
Taiwan · Delayed Price · Currency is TWD 83.40
+3.80 (4.77%)
Jan 22, 2026, 1:32 PM CST
Winston Medical Supply Revenue
Winston Medical Supply had revenue of 358.83M TWD in the half year ending June 30, 2025, with 5.70% growth. This brings the company's revenue in the last twelve months to 724.35M, up 3.61% year-over-year. In the year 2024, Winston Medical Supply had annual revenue of 695.08M, down -1.97%.
Revenue (ttm)
724.35M
Revenue Growth
+3.61%
P/S Ratio
2.02
Revenue / Employee
4.02M
Employees
180
Market Cap
1.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 695.08M | -14.00M | -1.97% |
| Dec 31, 2023 | 709.07M | 102.56M | 16.91% |
| Dec 31, 2022 | 606.52M | 69.99M | 13.05% |
| Dec 31, 2021 | 536.53M | 31.41M | 6.22% |
| Dec 31, 2020 | 505.12M | 140.23M | 38.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TSH Biopharm Corporation | 1.27B |
| Anxo Pharmaceutical | 883.22M |
| Excelsior Biopharma | 859.77M |
| Prince Pharmaceutical | 798.27M |
| DV Biomed | 712.61M |
| GeneFerm Biotechnology | 654.88M |
| Tien Liang BioTech | 467.02M |
| Mediera | 240.30M |